DeepMed Research

Qilu Hospital of Shandong University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1890-01-01

Employees: -

Market Cap: -

Website: https://www.qiluhospital.com

Clinical Trials

Rapid Identification of MINOCA Based on Novel Biomarkers

Conditions: Copeptin
Identification
Myocardial Infarction With Non-obstructive Coronary Arteries
Grow Stimulation Expressed Gene 2
Prognosis

Interventions: Biological: blood biomarkers

First Posted Date: 2021-07-23

Last Posted Date: 2021-07-23

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 2616

Registration Number: NCT04974320

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking Imaging

Conditions: Cirrhotic Cardiomyopathy
Liver Cirrhosis

Interventions: Other: Not

First Posted Date: 2021-07-20

Last Posted Date: 2022-04-25

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 200

Registration Number: NCT04969055

Locations: 🇨🇳
Qilu Hospital , Shandong University, Jinan, Shandong, China

The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Phase 4

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Tofacitinib
Drug: Iguratimod
Drug: Pred

First Posted Date: 2021-06-16

Last Posted Date: 2023-11-18

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 100

Registration Number: NCT04928066

Locations: 🇨🇳
Qilu Hospital, Jinan, Shandong, China

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Phase 4

Active, not recruiting

Conditions: Interstitial Lung Disease
Pirfenidone
Connective Tissue Diseases

Interventions: Drug: Pirfenidone
Drug: DMARDs

First Posted Date: 2021-06-16

Last Posted Date: 2023-11-18

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 200

Registration Number: NCT04928586

Locations: 🇨🇳
Qilu Hospital, Jinan, Shandong, China

The Clinical Features and Pregnancy Outcomes of CTD Patients

Recruiting

Conditions: Pregnancy Related
Connective Tissue Diseases

Interventions: Drug: Prednisone
Drug: Hydroxychloroquine
Drug: Aspirin
Drug: low molecular weight heparin Enoxaparin

First Posted Date: 2021-06-09

Last Posted Date: 2023-11-18

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 126

Registration Number: NCT04918524

Locations: 🇨🇳
Qilu Hospital, Jinan, Shandong, China

Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Phase 2

Completed

Conditions: Thrombocytopenia

Interventions: Drug: Eltrombopag plus diacerein
Drug: Eltrombopag

First Posted Date: 2021-06-08

Last Posted Date: 2023-10-19

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 102

Registration Number: NCT04917679

Locations: 🇨🇳
Qilu hospital, Shandong University, Jinan, Shandong, China

The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis

Completed

Conditions: Liver Cirrhosis
Esophageal and Gastric Varices

Interventions: Dietary Supplement: nutrient solution

First Posted Date: 2021-04-01

Last Posted Date: 2022-03-02

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 397

Registration Number: NCT04823780

Locations: 🇨🇳
Qilu Hospital , Shandong University, Jinan, Shandong, China

Imaging Evaluation of Central Nervous Autoimmune Diseases

Conditions: NMO Spectrum Disorder
MS (Multiple Sclerosis)

Interventions: Diagnostic Test: MRI

First Posted Date: 2021-03-30

Last Posted Date: 2021-03-30

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 300

Registration Number: NCT04822623

Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer

Not Applicable

Conditions: Small Cell Lung Cancer

Interventions: Drug: Camrelizumab Anti-PD-1 antibody Fluzoparib PARP inhibitors

First Posted Date: 2021-03-04

Last Posted Date: 2021-03-04

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 20

Registration Number: NCT04782089

Development and Validation of a Simple-to-use Nomogram for Predicting In-hospital Mortality in Acute Heart Failure Patients Undergoing Continuous Renal Replacement Therapy

Conditions: Heart Failure Acute

Interventions: Other: no intervention

First Posted Date: 2021-02-12

Last Posted Date: 2021-02-12

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 226

Registration Number: NCT04751838

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy